Business & M&A
InMode Receives Unsolicited $16.20-Per-Share Acquisition Proposal — Aesthetic Device Maker Faces Takeover Interest
CEO group submits bid for the publicly traded energy-based device manufacturer.
Photo: Yan Krukau / Pexels
AI Inside MedSpa Intelligence · Jun 26, 2026
InMode Ltd. has received an unsolicited acquisition proposal valuing the company at $16.20 per share, according to SEC filings. The proposal comes from a group led by the company's CEO, signaling confidence in InMode's market position and asset value despite recent stock volatility.
InMode manufactures energy-based aesthetic devices including radiofrequency, ultrasound, and laser platforms widely used in medspa and surgical settings. The acquisition interest underscores the strategic value of established device portfolios in the consolidating aesthetic market. For practice owners using InMode equipment, any transaction could affect product roadmaps, pricing, and support structures.
InMode receives unsolicited $16.20-per-share acquisition proposal from CEO-led group.
Source: original report ↗
Frequently asked questions
What does InMode's acquisition proposal mean for medspa owners using their devices?
An acquisition could affect product roadmaps, pricing, and support structures for InMode equipment users. Medspa owners should monitor the deal's progress and maintain relationships with InMode's support team to understand any potential changes to service, training, or future device releases.
Who is bidding to acquire InMode and at what price?
A group led by InMode's CEO has submitted an unsolicited acquisition proposal valuing the company at $16.20 per share. This bid signals confidence in InMode's market position and asset value despite recent stock volatility.
What types of aesthetic devices does InMode manufacture?
InMode manufactures energy-based aesthetic devices including radiofrequency, ultrasound, and laser platforms. These devices are widely used in medspa and surgical settings for various aesthetic procedures.
Why is there acquisition interest in InMode right now?
The acquisition interest reflects the strategic value of established device portfolios in the consolidating aesthetic market. InMode's established product lines and market presence make it an attractive acquisition target for investors seeking exposure to the growing medical aesthetics sector.
Could an InMode acquisition affect device pricing for medspa practices?
Yes, pricing could potentially change under new ownership as part of restructuring or strategic repositioning. Practices should document current pricing agreements and consider negotiating long-term contracts before any transaction closes.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief every morning. The owners who read it never get blindsided.
Get the edge · $20/mo Join the owners who run ahead of the industry. Cancel anytime, one click.
